COMMUNIQUÉS West-GlobeNewswire

Recce Pharmaceuticals Announces A$5.0 million Placement & Launches A$10.8 million Entitlement Offer to Shareholders

10/04/2025 - 14:00

A$5.0 million commitment received from Australian-based private investor A$10.8 million Entitlement Offer at the same offer price as the placement Funds to support Phase III Topical clinical trials in Indonesia and [...]

Calidi Biotherapeutics Announces Appointment of Guy Travis Clifton, MD as Chief Medical Officer, Consultant and Advisor

10/04/2025 - 14:00

SAN DIEGO, April 10, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) (“Calidi”), a clinical-stage biotechnology company developing a new generation of targeted antitumor virotherapies, today [...]

Daxor Corporation Submits 510(k) to FDA for Next-Generation Blood Volume Analyzer

10/04/2025 - 14:00

Advanced BVA System Designed for Faster, Simpler Bedside Testing Oak Ridge, TN, April 10, 2025 (GLOBE NEWSWIRE) -- Daxor Corporation (Nasdaq: DXR), a leader in blood volume measurement technology, announces today the [...]

Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors

10/04/2025 - 14:00

Dansey, a former senior executive at Pfizer and Seagen, Inc., brings extensive experience in immuno-oncology and drug development Board appointment reinforces Company’s commitment to advancing Jankistomig, a one-of-a- [...]

Theriva Biologics Announces Presentation of Data from the Phase 1b/2a Clinical Trial of SYN-004 (ribaxamase) in Allogeneic Hematopoietic Cell Transplant Recipients

10/04/2025 - 14:00

Interim blinded safety and pharmacokinetic data to be presented at the Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID Global) ROCKVILLE, Md., April 10, 2025 (GLOBE NEWSWIRE [...]

Avalyn to Participate in Upcoming Investor Conference in April

10/04/2025 - 14:00

CAMBRIDGE, Mass., April 10, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. , a clinical-stage biopharmaceutical company focused on development of inhaled therapies for the treatment of life-threatening pulmonary diseases, [...]

Oculis Completes Enrollment in both DIAMOND Phase 3 Trials of OCS-01 in Diabetic Macular Edema

10/04/2025 - 14:00

DIAMOND is the first and only pivotal trial program ever conducted with a topical treatment for diabetic macular edema (DME) Over 800 patients randomized in DIAMOND-1 or DIAMOND-2 Phase 3 trials at an industry-leading [...]

Evaxion to present at World Vaccine Congress

10/04/2025 - 14:00

Congress will take place April 21-24, 2025, in Washington, D.C. COPENHAGEN, Denmark, April 10, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI- [...]

VitalHub Announces Recommended Cash Acquisition of Induction Healthcare Group PLC

10/04/2025 - 14:00

TORONTO, April 10, 2025 (GLOBE NEWSWIRE) -- VitalHub Corp. (the “Company” or “VitalHub”) (TSX: VHI) (OTCQX: VHIBF) is pleased to announce that it has agreed the terms and conditions of a recommended cash acquisition to [...]

La Commission européenne approuve la quadrithérapie à base de DARZALEX® (daratumumab) par voie sous-cutanée de Johnson & Johnson chez les patients atteints d’un myélome multiple nouvellement diagnostiqué, quelle que soit leur éligibilité à la greffe

10/04/2025 - 14:11

Cet approbation renforce l’utilisation du daratumumab en traitement fondamental chez les patients atteints d’un myélome multiple nouvellement diagnostiqué, en faisant ainsi le seul anticorps anti-CD38 pour tous les [...]

Clearmind Medicine Announces First U.S. Clinical Site Initiation for CMND-100 Clinical Trial in Patients with Alcohol Use Disorder

10/04/2025 - 14:25

Vancouver, Canada, April 10, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel [...]

Conduit Pharmaceuticals Announces up to $1,000,000 Share Repurchase Program

10/04/2025 - 14:30

NAPLES, Fla. and CAMBRIDGE, United Kingdom, April 10, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT ) (" Conduit " or the “ Company ”) today announced that its Board of Directors has authorized a [...]

Pluri Announces Expansion of Intellectual Property Portfolio with Two Granted Patents for 3D Expansion of Immune Cells in the United States and Israel

10/04/2025 - 14:30

Latest granted patents reinforce Pluri’s position as a leader in Mucosal- A ssociated I nvariant T ( “ MAIT ” ) cell -based cell therap ies for solid cancers Pluri’s MAIT platform enable s commercial scale production of [...]

Inozyme Pharma Announces JBMR Plus Publication Demonstrating Real-World Impact of ENPP1 Deficiency

10/04/2025 - 14:30

- Data from the largest retrospective analysis of ENPP1 Deficiency provides insights into the evolution of the disease’s serious cardiovascular and musculoskeletal complications - - Findings highlight the urgent need [...]

TYG Training Launches First Canadian Location in Whitby, Bringing Community-Driven Fitness to Durham Region

10/04/2025 - 14:30

WHITBY, Ontario, April 10, 2025 (GLOBE NEWSWIRE) -- TYG Training (TYG) has officially opened its first Canadian location in Whitby at 910 Dundas St W, Unit 104 — a boutique strength and conditioning club designed for [...]

Geoff Dow, PhD, Infectious Disease Product Development Expert, to Discuss Babesiosis at Healing Lyme Summit, April 15-21

10/04/2025 - 14:31

WASHINGTON, April 10, 2025 (GLOBE NEWSWIRE) -- Geoff Dow, infectious disease product development expert and chief executive officer of 60 Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) (“60 Degrees” or the “Company [...]

Cuprina Holdings (Cayman) Limited Announces Pricing of $12 million Initial Public Offering

10/04/2025 - 14:35

SINGAPORE, April 10, 2025 (GLOBE NEWSWIRE) -- Cuprina Holdings (Cayman) Limited (“ CUPR ” or “the Company ”), a biomedical and biotechnology company dedicated to the development and commercialization of products for the [...]

Senti Bio Bolsters Scientific Advisory Board with Appointment of James B. Trager, Ph.D.

10/04/2025 - 14:45

Industry leader in the development and application of cellular therapies, including CAR NK products, for cancer Led development of multiple clinical candidates from conception through IND and early clinical development [...]

Over 53 Million Myeloma Milestones Shared During 2025 Myeloma Action Month

10/04/2025 - 14:45

Myeloma Action Month Global Campaign Celebrates Resilience, Strengthens Connections, and Inspires Hope in 52 Countries Worldwide STUDIO CITY, Calif., April 10, 2025 (GLOBE NEWSWIRE) -- At the conclusion of this year’s [...]